Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Yiqing Biotechnology is a leading Chinese manufacturer of pharmaceutical capsules (including gelatin, enteric, HPMC, Pullulan, and TiO2-free capsules), supplying both the nutraceutical and pharma industries. The company's focus is on capsule shell materials and technology, not clinical therapeutics or APIs. There are no clinical trial results, as Yiqing is not a drug developer but rather a supplier of pharmaceutical-grade capsule shells.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Yiqing Biotechnology.